Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email

Intellia Therapeutics (NTLA) News Today

→ On June 10, Nvidia makes its next big move (From Weiss Ratings) (Ad)
Free NTLA Stock Alerts
$21.38
-0.72 (-3.26%)
(As of 05/31/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends
June 1 at 2:00 AM | americanbankingnews.com
Intellia Therapeutics, Inc. Expected to Post FY2024 Earnings of ($4.50) Per Share (NASDAQ:NTLA)
May 31 at 8:25 AM | marketbeat.com
FY2024 EPS Estimates for Intellia Therapeutics, Inc. Increased by Chardan Capital (NASDAQ:NTLA)
Intellia Therapeutics, Inc. (NASDAQ:NTLA - Free Report) - Research analysts at Chardan Capital increased their FY2024 earnings per share (EPS) estimates for shares of Intellia Therapeutics in a research note issued to investors on Tuesday, May 28th. Chardan Capital analyst Y. Livshits now expects
May 28, 2024 | marketbeat.com
Intellia Therapeutics (NASDAQ:NTLA) Trading Down 3.6%
Intellia Therapeutics (NASDAQ:NTLA) Shares Down 3.6%
May 25, 2024 | americanbankingnews.com
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Given Consensus Rating of "Moderate Buy" by Analysts
May 22, 2024 | fool.com
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
May 17, 2024 | marketbeat.com
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Sold by Nikko Asset Management Americas Inc.
Nikko Asset Management Americas Inc. cut its holdings in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA - Free Report) by 1.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,478,562 shares of the company's stock
May 14, 2024 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA), Iovance Biotherapeutics (IOVA) and Intellia Therapeutics (NTLA)
May 13, 2024 | marketbeat.com
Intellia Therapeutics (NASDAQ:NTLA) Trading Up 8.5% After Analyst Upgrade
Intellia Therapeutics (NASDAQ:NTLA) Trading 8.5% Higher on Analyst Upgrade
May 13, 2024 | seekingalpha.com
Intellia Therapeutics: 3 Near-Term Pivotal In Vivo Gene Therapies
May 12, 2024 | finance.yahoo.com
Earnings Beat: Intellia Therapeutics, Inc. (NASDAQ:NTLA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
May 11, 2024 | marketbeat.com
Intellia Therapeutics (NASDAQ:NTLA) Raised to "Sell" at StockNews.com
StockNews.com raised shares of Intellia Therapeutics to a "sell" rating in a research report on Friday.
May 10, 2024 | marketbeat.com
Intellia Therapeutics (NASDAQ:NTLA) Price Target Lowered to $29.00 at Citigroup
Citigroup cut their price target on Intellia Therapeutics from $31.00 to $29.00 and set a "neutral" rating for the company in a report on Friday.
May 10, 2024 | markets.businessinsider.com
Barclays Reaffirms Their Buy Rating on Intellia Therapeutics (NTLA)
May 10, 2024 | marketbeat.com
BMO Capital Markets Raises Intellia Therapeutics (NASDAQ:NTLA) Price Target to $70.00
BMO Capital Markets lifted their target price on Intellia Therapeutics from $62.00 to $70.00 and gave the company an "outperform" rating in a report on Friday.
May 10, 2024 | fool.com
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
May 10, 2024 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: Tarsus Pharmaceuticals (TARS), Collegium Pharmaceutical (COLL) and Intellia Therapeutics (NTLA)
May 10, 2024 | finance.yahoo.com
Intellia Therapeutics First Quarter 2024 Earnings: Beats Expectations
May 9, 2024 | msn.com
NTLA Stock Earnings: Intellia Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 9, 2024 | marketbeat.com
Intellia Therapeutics (NASDAQ:NTLA) Shares Gap Up to $23.00
Intellia Therapeutics (NASDAQ:NTLA) Shares Gap Up to $23.00
May 9, 2024 | finanznachrichten.de
Intellia Therapeutics, Inc.: Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
May 9, 2024 | seekingalpha.com
Crispr Therapeutics Q1 Earnings: Casgevy Launch Tip Of Gene Editing Iceberg
May 9, 2024 | globenewswire.com
Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
May 5, 2024 | marketbeat.com
265,981 Shares in Intellia Therapeutics, Inc. (NASDAQ:NTLA) Acquired by Vestmark Advisory Solutions Inc.
Vestmark Advisory Solutions Inc. bought a new stake in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 265,981 shares of the company's stock, valued at approximately $8,110,000. Vest
May 3, 2024 | investorplace.com
Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street's Radar
May 3, 2024 | marketbeat.com
Intellia Therapeutics (NTLA) Set to Announce Quarterly Earnings on Thursday
Intellia Therapeutics (NASDAQ:NTLA) will be releasing earnings before the market opens on Thursday, May 9, Zacks reports.
May 3, 2024 | investing.com
Intellia Therapeutics Inc (NTLA) Earnings Dates & Reports
May 2, 2024 | finance.yahoo.com
Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2024 Earnings and Company Updates
May 2, 2024 | globenewswire.com
Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2024 Earnings and Company Updates
May 2, 2024 | investorplace.com
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
April 30, 2024 | seekingalpha.com
Invest In A Revolutionary Gene Therapy With CRISPR Therapeutics
April 29, 2024 | marketbeat.com
Intellia Therapeutics (NASDAQ:NTLA) Trading Up 6.8%
Intellia Therapeutics (NASDAQ:NTLA) Shares Up 6.8%
April 29, 2024 | globenewswire.com
Intellia Therapeutics to Present Updated Data from Phase 1/2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the EAACI Congress 2024
April 28, 2024 | marketbeat.com
abrdn plc Buys New Stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
abrdn plc bought a new stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 154,269 shares of the company's stock, valued at approximately $4,704,000. abrd
April 27, 2024 | investing.com
Intellia Therapeutics Inc (NTLA)
April 25, 2024 | marketbeat.com
Intellia Therapeutics (NASDAQ:NTLA) Reaches New 1-Year Low at $19.77
Intellia Therapeutics (NASDAQ:NTLA) Hits New 52-Week Low at $19.77
April 25, 2024 | finance.yahoo.com
Intellia (NTLA) to Report Q1 Earnings: What's in the Cards?
April 23, 2024 | marketbeat.com
Intellia Therapeutics' (NTLA) Neutral Rating Reaffirmed at Wedbush
Wedbush reaffirmed a "neutral" rating and set a $29.00 price objective on shares of Intellia Therapeutics in a report on Tuesday.
April 20, 2024 | marketbeat.com
Federated Hermes Inc. Increases Stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Federated Hermes Inc. grew its position in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA - Free Report) by 13.8% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,016,300 shares of the company's stock after buying an additional 244,722
April 17, 2024 | marketbeat.com
Sumitomo Mitsui Trust Holdings Inc. Sells 41,733 Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Sumitomo Mitsui Trust Holdings Inc. lessened its holdings in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA - Free Report) by 1.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,478,562 shares of the co
April 15, 2024 | marketbeat.com
Intellia Therapeutics (NASDAQ:NTLA) Reaches New 12-Month Low at $22.51
Intellia Therapeutics (NASDAQ:NTLA) Hits New 1-Year Low at $22.51
April 15, 2024 | marketbeat.com
Mirae Asset Global Investments Co. Ltd. Sells 100,885 Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Mirae Asset Global Investments Co. Ltd. lowered its position in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA - Free Report) by 35.2% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 185,858 shares of the company's sto
April 13, 2024 | marketbeat.com
Capital Advisors Inc. OK Acquires 73,379 Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Capital Advisors Inc. OK boosted its holdings in shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA - Free Report) by 34.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 284,738 sha
April 12, 2024 | fool.com
Cathie Wood Goes Bargain Hunting. 2 Stocks She Bought This Week.
April 9, 2024 | fool.com
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
April 2, 2024 | marketbeat.com
Intellia Therapeutics (NASDAQ:NTLA) Shares Down 7.1%
Intellia Therapeutics (NASDAQ:NTLA) Stock Price Down 7.1%
March 28, 2024 | benzinga.com
Smart Money Is Betting Big In NTLA Options
March 28, 2024 | marketbeat.com
ARK Investment Management LLC Grows Stake in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
ARK Investment Management LLC boosted its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA - Free Report) by 14.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,412,449 shares of the company's stoc
March 28, 2024 | fool.com
Better Cathie Wood Stock: Moderna vs. Intellia
March 22, 2024 | marketwatch.com
Intellia Therapeutics Ends Co-Development Agreement With Regeneron
March 22, 2024 | msn.com
Intellia opts out of hemophilia pact with Regeneron
Get Intellia Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NTLA and its competitors with MarketBeat's FREE daily newsletter.

Trump conviction scandal exposed (Ad)

In this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election…

To get all the details, go here now.

NTLA Media Mentions By Week

NTLA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NTLA
News Sentiment
▼
1.12

0.82
▲
Average
Medical
News Sentiment

NTLA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NTLA Articles
This Week
▼
5

4
▲
NTLA Articles
Average Week

Get Intellia Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NTLA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:NTLA) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners
Must-See: Elon’s New Invention is Absolutely Insane
InvestorPlace
The #1 Crypto That You Don’t Own… Yet
Crypto 101 Media
Biden Nomination CANCELED?
The Freeport Society
On June 10, Nvidia makes its next big move
Weiss Ratings
MAJOR BUY SIGNAL: Move Fast, Washington/Pelosi/Mill…
Altimetry
Unlock Explosive Gains with This Defense Stock
Behind the Markets
Elon’s Revenge on Biden
TradeSmith
Claim Your Complimentary Bitcoin Reward
Crypto Swap Profits